Associate Professor Tonny Veenith MBBS, PhD(cantab), MRCP, FRCA, FFICM, EDIC

Dr Tonny Veenith

Institute of Inflammation and Ageing
Deputy Director of Research, Neurosciences and Trauma
Hon. Consultant in Neurocritical care and Critical Care Medicine

Tonny Veenith is Deputy Director of the Trauma, Neuroscience and Ophthalmology group within the Institute of Inflammation and Ageing.

He is also the deputy clinical director of research at the University Hospital Birmingham and was appointed as Macintosh professor for 2020-2022. He is an associate professor at University of Birmingham, and an Honorary Consultant in University Hospitals Birmingham NHS trust. 

https://orcid.org/0000-0002-4125-8804

https://scholar.google.com/citations?user=VRdZVj4AAAAJ&hl=en

https://www.researchgate.net/profile/Tonny-VeenithT

Qualifications

  • MBBS
  • PhD(cantab)
  • MRCP
  • FRCA
  • EDIC
  • FFICM

Biography

Tonny Veenith is Deputy Director of the Trauma, Neuroscience and Ophthalmology group within the Institute of Inflammation and Ageing. He is also the deputy clinical director of research at the University Hospital Birmingham and was appointed as Macintosh professor for 2020-2022. He is an associate professor at UoB.

Tonny Veenith researches translational mechanisms and management of acute brain injury, trauma and critical illness with a particular interest in traumatic brain injury, neurodegeneration after critical illness and organ failure following trauma. He closely works with a network of collaborators within the University of Birmingham and worldwide. His research aims to translate new mechanistic findings into patient benefit, covering mechanistic research, translational studies (MEND, CATALYST trials), and large clinical trials (e.g. SoS Trial, ERASER trial). Tonny is also an associate editor for the Journal of Intensive Care Medicine.

Teaching

Dr Vennith is an enthusiastic teacher, regular supervisor and examiner for MD and PhD students, and a sought-after speaker. Dr Veenith also contributes to guidelines, curricula, and textbooks nationally and internationally. Dr Veenith will consider PhD students and is persuing amazing opportunities in Critical Care Medicine.

Publications

Recent publications

Article

Lamerton, R, Marcial-Juarez, E, Faustini, S, Perez-Toledo, M, Goodall, M, Jossi, S, Newby, ML, Chapple, I, Dietrich, T, Veenith, T, Shields, A, Harper, L, Henderson, I, Rayes, J, Wraith, D, Watson, S, Crispin, M, Drayson, M, Richter, A & Cunningham, A 2022, 'SARS-CoV-2 spike- and nucleoprotein-specific antibodies induced after vaccination or infection promote classical complement activation', Frontiers in immunology. <http://frontiersin.org/Immunology>

Veenith, T, Fisher, BA, Slade, D, Rowe, A, Sharpe, R, Thickett, DR, Whitehouse, T, Rowland, M, Scriven, J, Parekh, D, Bowden, SJ, Savage, JS, Richards, D, Bion, J, Kearns, P, Gates, S & CATALYST Trial Investigators 2021, 'CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults', BMJ open, vol. 11, no. 11, e050202. https://doi.org/10.1136/bmjopen-2021-050202

Sokoliuk, R, Degano, G, Banellis, L, Melloni, L, Hayton, T, Sturman, S, Veenith, T, Yakoub, KM, Belli, A, Noppeney, U & Cruse, D 2021, 'Covert speech comprehension predicts recovery from acute unresponsive states', Annals of Neurology, vol. 89, no. 4, pp. 646-656. https://doi.org/10.1002/ana.25995

Faustini, S, Jossi, S, Perez-Toledo, M, Shields, A, Allen, JD, Watanabe, Y, Newby, ML, Cook, A, Willcox, C, Salim, M, Goodall, M, Heaney, J, Marcial-Juarez, E, Morley, G, Torlinska, B, Wraith, D, Veenith, T, Harding, S, Jolles, S, Mark, PJ, Plant, T, Huissoon, A, O’Shea, MK, Willcox, B, Drayson, M, Crispin, M, Cunningham, A & Richter, A 2021, 'Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva', Immunology. https://doi.org/10.1111/imm.13349

GSTT CovidCollaborative 2021, 'Individual factors including age, BMI and heritable factors underlie temperature variation in sickness and in health: an observational, multi-cohort study', The journals of gerontology. Series A, Biological sciences and medical sciences. https://doi.org/10.1093/gerona/glab295

CATALYST investigators, Fisher, B, Veenith, T, Slade, D, Gaskell, C, Rowland, M, Whitehouse, T, Scriven, J, Parekh, D, Balasubramaniam, M, Cooke, G, Morley, N, Gabriel, Z, Wise, M, Porter, J, McShane, H, Ho, L-P, Newsome, P, Rowe, A, Sharpe, R, Thickett, D, Bion, J, Gates, S, Richards, D & Kearns, P 2021, 'Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial', The Lancet Respiratory Medicine. https://doi.org/10.1016/S2213-2600(21)00460-4

Yang, M, He, Q, Gao, F, Nirantharakumar, K, Veenith, T, Qin, X, Page, AT, Wong, MCS, Huang, J, Kuo, ZC, Xia, B, Zhang, C, He, Y, Meng, W, Yuan, J & Pan, Y 2021, 'Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials', BMC Medicine, vol. 19, no. 1, 316. https://doi.org/10.1186/s12916-021-02180-5

Queen Elizabeth Hospital Birmingham COVID-19 Research Team 2021, 'Rehabilitation levels in patients with COVID-19 admitted to intensive care requiring invasive ventilation. An observational study', Annals of the American Thoracic Society, vol. 18, no. 1, pp. 122-129. https://doi.org/10.1513/AnnalsATS.202005-560OC

Courtie, EF, Kale, AU, Hui, BTK, Liu, X, Capewell, NI, Bishop, JRB, Whitehouse, T, Veenith, T, Logan, A, Denniston, AK & Blanch, RJ 2021, 'Stability of OCT and OCTA in the intensive therapy unit setting', Diagnostics (Basel, Switzerland), vol. 11, no. 8, 1516. https://doi.org/10.3390/diagnostics11081516

O'Donnell, A, Pauli, R, Banellis, L, Sokoliuk, R, Hayton, T, Sturman, S, Veenith, T, Yakoub, K, Belli, T, Chennu, S & Cruse, D 2021, 'The prognostic value of resting-state EEG in acute post-traumatic unresponsive states', Brain Communications, vol. 3, no. 2, fcab017. https://doi.org/10.1093/braincomms/fcab017

Oakley, C, Pascoe, C, Balthazor, D, Bennett, D, Gautam, N, Isaac, J, Isherwood, P, Matthews, T, Murphy, N, Oelofse, T, Patel, J, Snelson, C, Richardson, C, Willson, J, Wyton, F, Veenith, T & Whitehouse, T 2020, 'Assembly Line ICU: what the Long Shops taught us about managing surge capacity for COVID-19', BMJ open quality, vol. 9, no. 4, e001117. https://doi.org/10.1136/bmjoq-2020-001117

Faustini, SE, Jossi, SE, Perez-Toledo, M, Shields, A, Allen, JD, Watanabe, Y, Newby, ML, Cook, A, Willcox, CR, Salim, M, Goodall, M, Heaney, JL, Marcial-Juarez, E, Morley, GL, Torlinska, B, Wraith, DC, Veenith, T, Harding, S, Jolles, S, Mark, PJ, Plant, T, Huissoon, A, O'Shea, MK, Willcox, BE, Drayson, MT, Crispin, M, Cunningham, AF & Richter, AG 2020, 'Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection', medRxiv. https://doi.org/10.1101/2020.06.16.20133025

Preprint

Veenith, T, Fisher, BA, Slade, D, Rowe, A, Sharpe, R, Thickett, DR, Whitehouse, T, Rowland, M, Scriven, J, Parekh, D, Bowden, SJ, Savage, JS, Richards, D, Bion, J, Kearns, P & Gates, S 2021 'CATALYST trial protocol: a multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults' medRxiv, pp. 1-15. https://doi.org/10.1101/2021.02.10.21251478

Lamerton, RE, Juarez, EM, Faustini, SE, Perez-Toledo, ME, Goodall, M, Jossi, SE, Newby, ML, Chapple, I, Dietrich, T, Veenith, T, Shields, AM, Harper, L, Henderson, IR, Rayes, J, Wraith, DC, Watson, SP, Crispin, M, Drayson, MT, Richter, AG & Cunningham, AF 2021 'In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens' medRxiv. https://doi.org/10.1101/2021.11.22.21266681

Fisher, BA, Veenith, T, Slade, D, Gaskell, C, Rowland, M, Whitehouse, T, Scriven, J, Parekh, D, Balasubramaniam, MS, Cooke, G, Morley, N, Gabriel, Z, Wise, MP, Porter, J, McShane, H, Ho, L-P, Newsome, PN, Rowe, A, Sharpe, R, Thickett, DR, Bion, J, Gates, S, Richards, D & Kearns, P 2021 'Namilumab or infliximab compared to standard of care in hospitalised patients with COVID-19 (CATALYST): a phase 2 randomised adaptive trial' medRxiv, pp. 1-26. https://doi.org/10.1101/2021.06.02.21258204

View all publications in research portal